45-1 Ramsey Road, Shirley, NY 11967, USA
USA: 1-631-871-5806
Europe: 44-207-048-3343
Fax: 1-631-207-8356

CAR Targeting Leukemia-specific Antigens

As a leading service provider, Creative Biolabs provides customer with first-class CellRapeutics™ Chimeric Antigen Receptor (CAR) targets various leukemia-specific antigens. Our excellent scientists with many years of experience have successfully established a unique and unparalleled CAR construction and production platform.

CAR targeting Leukemia-specific antigens

Shannon L. Maude, David T. Teachey, David L. Porter, and Stephan A. Grupp. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. 2015; Blood: 125 (26). 

 Leukemia is a type of blood cancer, which starts in the bone marrow and subsequently leads to large amount of abnormal white blood cells (WBCs). These WBCs which lose normal function and grow quickly and finally crowd out the normal ones. It can be further divided into four main subtypes: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). According to the onset of leukemia, ALL and AML develop quickly; while CLL and CML perform slowly. The cause of leukemia is still unknown. However, several factors have been characterized to play key roles in the arising of leukemia, such as gene mutation which may be caused by chemical exposure or radiation exposure, viral infection and heredity such as a family history of Leukemia or Down syndrome. Leukemia is usually treated with chemotherapy, radiation therapy, and stem cell transplantation if possible. However, chemotherapy and radiation therapy always have serious side effects and potential complications. Emerging studies have shown adoptive immunotherapy such as CAR modified T cells or NK cells therapy that is the most promising approach for cancer treatment, which can get over the adverse effects of traditional therapies. 

Creative Biolabs now provides you with custom construction and production services of many types of CARs against Leukemia antigens including CD19, k-light chain, CD33, CD123, WT1, Pr3, HNE, survivin and OFA-iLRP, all of which are listed in the following table. Different types of CARs and various styles of generation are also shown in this table. Besides these, we also have highly tailored service to meet the most specific needs from customers. If you need any help about CARs, please feel free to contact us.

Products against Leukemia-specific antigens

Target antigen Receptor type Product
CD19 Ly49H-CD3ζ Inquiry
CD19 IL-13-CD3ζ Inquiry
CD19 ScFv-CD28-41BB-CD3ζ pCDCAR1 CD19 h(28BBζ), T
CD19 ScFv-CD28 Inquiry
CD19 IL-13-CD28-4-1BB-CD3ζ Inquiry
CD19 Heregulin-CD3ζ Inquiry
CD19 ScFv-b2c-CD3ζ pCDCAR1 CD19 h(b2cζ), T
CD19 ScFv-41BB-CD3ζ vs. CD3ζ Inquiry
k-light chain ScFv-CD3ζ (VZV) Inquiry
CD33 ScFv-CD28-CD3ζ pCDCAR1 CD33 h(28ζ), T
CD33 ScFv-CD8-41BB-CD3ζ pCDCAR1 CD33 h(BBζ), T
CD123 ScFv-CD28-CD3ζ pCDCAR1 CD123 h(28ζ), T
WT1 ScFv-CD8-41BB-CD3ζ Inquiry
Pr3 ScFv-CD8-41BB-CD3ζ Inquiry
HNE ScFv-CD28-CD3ζ Inquiry
survivin ScFv-CD8-41BB-CD3ζ Inquiry
OFA-iLRP ScFv-CD28-CD3ζ Inquiry

Online Inquiry

*E-mail Address:
*Service & Products Interested:
Project Description:
*Verification Code:
Please input "biolabs"(case insensitive) as verification code.

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356

Ringstrasse 4, 64401 Gross-Bieberau, Germany
Tel: 44-207-048-3343


To view the contact information for a specific location, select the desired country: